Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore…
7 analysts rate PBH Buy on consensus.
Consensus price target: $67.80 (+37.08% upside from $49.46)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Zerillo Jeffrey Senior VP Operations | May 11, 2026 | Sale | 351 | $18.35K |
| Zerillo Jeffrey Senior VP Operations | May 5, 2026 | Sale | 346 | $19.14K |
| Zerillo Jeffrey Senior VP Operations | May 5, 2026 | Sale | 1,207 | $66.37K |
| Zerillo Jeffrey Senior VP Operations | Feb 11, 2026 | Sale | 1,000 | $65.93K |
| Zerillo Jeffrey Senior VP Operations | Dec 1, 2025 | Sale | 281 | $16.86K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2026 | $1.09B | -4.31% | $190.3M |
| 2025 | $1.14B | +1.1% | $214.61M |
| 2024 | $1.13B | -0.21% | $209.34M |
Stock data for PBH: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics